Dopamine receptor D4 (DRD4) polymorphisms with reduced functional potency intensify atrophy in syndrome-specific sites of frontotemporal dementia.
Butler PM, Chiong W, Perry DC, Miller ZA, Gennatas ED, Brown JA, Pasquini L, Karydas A, Dokuru D, Coppola G, Sturm VE, Boxer AL, Gorno-Tempini ML, Rosen HJ, Kramer JH, Miller BL, Seeley WW.
Butler PM, et al. Among authors: boxer al.
Neuroimage Clin. 2019;23:101822. doi: 10.1016/j.nicl.2019.101822. Epub 2019 Apr 10.
Neuroimage Clin. 2019.
PMID: 31003069
Free PMC article.